Vascularized Heart Organoid Platform

About Bullseye Biosciences

Bullseye Biosciences is pioneering the development of scalable and reproducible vascularized organoids—'mini-organs' in a dish—to overcome a major limitation in the field: the lack of functional blood vessels, which restricts organoid viability, growth, and physiological relevance. The company integrates expertise in stem cell biology, novel hardware, and AI/ML software to create advanced heart and liver organoid systems, with plans to expand to all organ types. As a pre-revenue, private startup, it is positioning itself as a platform and services provider to the pharmaceutical and academic research sectors, leveraging a strong scientific foundation evidenced by extensive peer-reviewed publications from its founding team.

Therapeutic Areas

Other Drug discovery/toxicity screening, Disease modeling Drugs